Vanadyl Complexes (VOp-Dmada) Promote Healthy Aging by Regulating Electron Transport Mediated by Mitochondrial...

Area of Science:

• Biochemistry
• Gerontology
• Pharmacology

Background:

• Vanadium compounds are recognized for antidiabetic, antitumor, and anti-Alzheimer's properties.
• Investigating long-term effects of antidiabetic vanadyl complexes prompted the discovery of VOp-dmada's anti-aging potential.

Purpose of the Study:

• To evaluate the pro-healthy aging effects of vanadyl complexes, specifically VOp-dmada.
• To elucidate the underlying molecular mechanisms of VOp-dmada's anti-aging action.

Main Methods:

• Tested VOp-dmada in diverse model organisms (yeast, C. elegans, mice) and cell models (fibroblasts, thymic cells).
• Conducted mechanistic studies involving mitochondrial complex II, c-Myc/SKP2/SIRT3 signaling, and SDHA expression.
• Assessed reactive oxygen species (ROS) generation and the ROS-thioredoxin-interacting protein (TXNIP) pathway.

Main Results:

• VOp-dmada demonstrated pro-healthy aging effects across yeast, C. elegans, and SAMP8 mice.
• Attenuated cellular senescence in mouse embryonic fibroblasts and preserved thymic function in mice.
• Improved mitochondrial complex II integrity and function via c-Myc/SKP2/SIRT3/SDHA axis activation.
• Reduced ROS generation and disrupted the TXNIP vicious cycle.

Conclusions:

• VOp-dmada exhibits significant pro-healthy aging properties with a favorable chronic safety profile.
• Targeting mitochondrial complex II is a viable strategy for developing novel anti-aging agents.
• Vanadium complexes may offer therapeutic benefits beyond diabetes, extending to aging-related diseases.